The idea of a benchtop blood testing system only needing a few drops of blood has gotten a bad rap since Theranos’ collapse. But that hasn’t stopped Truvian Sciences from trying to develop its own system
Truvian Sciences Raises $27m As It Tries To Succeed Where Theranos Failed
By HCI
